Health Canada has authorized Eli Lilly’s Foundayo, a daily oral GLP-1 medication for adults with obesity or overweight with a related health problem, and the company expects it in pharmacies in January.
Health Canada approves Eli Lilly’s daily GLP-1 weight-loss pill Foundayo
Health Canada has authorized Eli Lilly’s Foundayo, a daily oral GLP-1 medication for adults with obesity or overweight with a related health problem, and the company expects it in pharmacies in January.
photographer not idenfied · Public domain · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.